NIH-funded research NIH-funded research

How gut bacteria shape your antibody defenses

Official title: Mechanisms of commensal bacteria induced humoral immunity

Funded at Upstate Medical University · NIH-11353771 · Data updated 2026-11-12

This grant explores how good gut bacteria help your body produce protective antibodies, with a focus on people who may be at risk for diabetes and other inflammation-related conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUpstate Medical University
NIH-funded
Lab location1 site (Syracuse, United States)
Project startJuly 15, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$407,500
NIH project number5R35GM147560-05
Project IDNIH-11353771 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals with diabetes-related immune concerns or those with a gut microbiome profile suggesting strong IgA responses, pending study design details.

Less likely to help

People without relevant immune or microbiome profiles may not receive direct benefit from this specific research.

What this research studies

Researchers will study how certain gut bacteria trigger the immune system to make IgA antibodies, including how these antibodies appear in the gut and in blood-forming sites like bone marrow. They plan to use broad, data-driven methods to identify the gene-level signals and interactions that drive systemic IgA responses from commensal bacteria. The findings could reveal new ways to support intestinal balance and possibly use friendly bacteria as vaccines in the future. The study aims to translate these insights into strategies to maintain health in people affected by diabetes-related immune changes.

Why it matters

Potential benefit: If successful, the work could lead to new approaches to support immune balance and possibly improve protection against infections for people with diabetes.

How similar studies have gone: Previous work has linked gut bacteria to systemic IgA and immune responses, but this project takes a broad, gene-level approach that is relatively novel.

Where this research is happening

  • Upstate Medical University
    Syracuse, United States
    Active

Researchers

  • Principal investigator: Wilmore, Joel R — Upstate Medical University
  • Study coordinator: Wilmore, Joel R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.